Canada’s adult-use cannabis sales fell to just under CA$150 million ($105.7 million) in February, the last full month of purchases before the COVID-19 crisis slammed the global economy. Eight of the 13 provinces and territories experienced lower sales in the month,...
The New York Stock Exchange has informed the U.S. Securities and Exchange Commission that it intends to delist the shares of beleaguered Canadian cannabis producer CannTrust on April 27, according to a public notification filed by the exchange. [include_post...
West Perth-based Little Green Pharma said it completed the first-ever commercial export of Australian-produced medical cannabis oil to the United Kingdom. The shipment moves Australia into competition with countries such as Canada and the Netherlands in the...
Quebec’s government-run cannabis franchise reported revenue of 110.8 million Canadian dollars ($90 million) for the October-December period, bringing sales for the first three quarters of its fiscal year to CA$219.5 million. That puts the Société québécoise du...
Canada’s federal, provincial and territorial governments have launched discussions to incorporate recreational cannabis into a nationwide trade deal, Marijuana Business Daily has learned. However, the talks - which began in December - are expected to be delayed as...
Embattled Canadian cannabis producer CannTrust shares will be delisted from the Toronto Stock Exchange on May 6 after market close, according to a TMX Group notice.
Ontario-based cannabis producer Aphria reported its fourth consecutive quarter of positive adjusted EBITDA, separating itself from competitors that raked up collective net losses exceeding CA$6 billion ($4.4 billion) in recent quarters. Aphria’s adjusted EBITDA - a...
Canadian cannabis extractor The Valens Co. reported its fourth straight quarterly profit, a rarity in a sector that experienced rampant losses throughout 2019 - the first calendar year of legalization. The British Columbia company reported adjusted EBITDA of 14...
The Danish Medicines Agency has put most inspections on hold because of the COVID-19 pandemic.
Australia’s government has identified specific "nonessential" industries in order to apply restricted operations to fight the novel coronavirus pandemic - and medical marijuana is not on that list. That means medical cannabis producers and their supply chains may...
Doctors in New Zealand no longer require Ministry of Health approval to prescribe Sativex, according to a new notice published in the country’s official Gazette – a move that could facilitate access to the pharmaceutical-grade, cannabis-based product.
Ontario’s cannabis store regulator has hit pause on new store authorizations, as the province’s existing retailers scramble to offer temporary curbside pickups and delivery.
